Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hologic, Inc. stock logo
HOLX
Hologic
$64.37
-0.6%
$60.84
$51.90
$84.67
$14.44B0.552.38 million shs1.79 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$73.45
-1.6%
$70.86
$60.56
$82.49
$9.09B0.871.72 million shs1.39 million shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$257.78
-1.6%
$252.66
$198.96
$265.72
$21.92B0.82641,688 shs555,606 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$318.90
-0.8%
$304.15
$250.05
$459.77
$9.24B1.47374,902 shs372,191 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hologic, Inc. stock logo
HOLX
Hologic
0.00%-0.42%+0.63%+5.66%-12.64%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.00%+1.90%+6.10%+16.10%+14.94%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.00%+0.61%+3.14%+17.19%+28.01%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%+3.48%+8.43%+10.82%-20.10%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hologic, Inc. stock logo
HOLX
Hologic
4.8085 of 5 stars
3.24.00.04.32.83.31.9
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.9955 of 5 stars
1.31.00.03.42.81.71.9
Labcorp Holdings Inc. stock logo
LH
Labcorp
4.4425 of 5 stars
2.42.02.54.23.52.51.3
Medpace Holdings, Inc. stock logo
MEDP
Medpace
4.4325 of 5 stars
2.12.00.04.62.14.22.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hologic, Inc. stock logo
HOLX
Hologic
2.41
Hold$77.4220.27% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.64
Moderate Buy$79.307.96% Upside
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.79
Moderate Buy$276.087.10% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.21
Hold$344.828.13% Upside

Current Analyst Ratings Breakdown

Latest LH, HOLX, HSIC, and MEDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingCautious ➝ Cautious
6/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.00
6/24/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Equal Weight$300.00
6/11/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.00
5/27/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/13/2025
Hologic, Inc. stock logo
HOLX
Hologic
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$77.00 ➝ $70.00
5/12/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$274.00 ➝ $290.00
5/6/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00
5/6/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$80.00 ➝ $75.00
5/6/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$90.00 ➝ $86.00
5/5/2025
Hologic, Inc. stock logo
HOLX
Hologic
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$77.00 ➝ $65.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.56$5.46 per share11.78$22.09 per share2.91
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$12.67B0.71$7.21 per share10.19$32.33 per share2.27
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.01B1.66$22.05 per share11.69$96.27 per share2.68
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.11B4.35$13.84 per share23.04$26.56 per share12.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3727.1613.932.3713.83%19.71%10.87%7/30/2025 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$390M$3.2022.9514.632.413.21%14.87%5.82%8/5/2025 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$746M$8.6529.8014.701.665.55%15.27%6.97%7/24/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.1024.3423.355.8019.31%54.36%20.81%7/21/2025 (Confirmed)

Latest LH, HOLX, HSIC, and MEDP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q3 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.05N/AN/AN/A$1.01 billionN/A
7/24/2025Q2 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.12N/AN/AN/A$3.49 billionN/A
7/21/2025Q2 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.01N/AN/AN/A$537.70 millionN/A
5/5/2025Q1 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.11$1.15+$0.04$0.88$3.24 billion$3.17 billion
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
4/29/2025Q1 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion
4/21/2025Q1 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.06$3.67+$0.61$3.67$528.38 million$558.57 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.881.12%N/A33.29%N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A

Latest LH, HOLX, HSIC, and MEDP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.25%5/29/20256/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hologic, Inc. stock logo
HOLX
Hologic
0.54
3.24
2.52
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.50
1.38
0.75
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.68
1.84
1.60
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73

Institutional Ownership

CompanyInstitutional Ownership
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%

Insider Ownership

CompanyInsider Ownership
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
1.14%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.85 million218.66 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000121.72 million120.33 millionOptionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
70,00083.70 million83.00 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90028.74 million22.91 millionOptionable

Recent News About These Companies

MEDP - Medpace Holdings Inc Key Metrics | Morningstar
MEDP - Medpace Holdings Inc Valuation | Morningstar
Medpace Holdings, Inc. (MEDP) Cash Flow - Yahoo Finance
Barclays Begins Coverage on Medpace (NASDAQ:MEDP)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hologic stock logo

Hologic NASDAQ:HOLX

$64.37 -0.41 (-0.63%)
Closing price 04:00 PM Eastern
Extended Trading
$63.96 -0.42 (-0.64%)
As of 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$73.45 -1.22 (-1.63%)
Closing price 04:00 PM Eastern
Extended Trading
$73.46 +0.00 (+0.01%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Labcorp stock logo

Labcorp NYSE:LH

$257.78 -4.11 (-1.57%)
Closing price 03:59 PM Eastern
Extended Trading
$257.92 +0.14 (+0.05%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Medpace stock logo

Medpace NASDAQ:MEDP

$318.90 -2.60 (-0.81%)
As of 04:00 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.